Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 2004

View Archived Issues

Serostim reduces visceral adipose tissue in HARS study

JNJ-7777120, a potent histamine H4 receptor antagonist with antiinflammatory activity

BMS describes novel, potent motilin agonist for treatment of GI hypomotility disorders

Efficacy of Menocare in management of menopausal symptoms

Par and Advancis to develop pulsatile amoxicillin

NexMed plans Chinese FSAD phase III study for Femprox

CytoGenix DNA antibacterial compound shows preclinical promise for sepsis

Alagebrium chloride approved as generic name for ALT-711

EMEA accepts Exubera filing

KOS-862 studied in combination with Gemzar for advanced solid tumors

Actiza NDA accepted for filing

Positive phase II results for BAL-5788

Nippon Shinyaku and Seikagaku terminate NS-7201 license agreement

Antigen Express to develop diagnostic kit for early detection of type 1 diabetes

Intrathecal Naropin recommended for approval in Europe

LifeSci Channel broadcasts ADA's 51st Postgraduate Course

Therapeutic antibodies with reduced side effects presented by Isis Innovation

Two novel series of SERM and their use reported by Lilly

Euroceltique claims new VR1/mGluR antagonists in a recent patent

AstraZeneca team develops new CXCR2 modulators for asthma, rhinitis, COPD, etc.

Aventis patent covers novel MCH receptor modulators for obesity and other uses

New antibacterial quinolines prepared and tested at Aventis

Novel anti-HIV agents in early development at BMS

Two series of sodium channel blockers discovered by Euroceltique scientists

FDA approval for Taxus Express2 stent

Adventrx files IND for BlockAide/CR phase Ib/IIa trials

LymphoStat-B selected for CMA Pilot 2 program

Positive results for MMH Malarex in comparative study with Camoquine

Kucera discovers novel antiviral compounds with potential for SARS

A new clinical trial to assess the efficacy and safety of RotaTeq(TM) against rotavirus infection

Antiretroviral efficacy of atazanavir plus enfuvirtide in HIV infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 11, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...